Evotec SE EVO
NASDAQ EVO
$1.60 -0.04 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evotec SE (EVO) Cost of Revenue (2009 - 2025)

Updated

Evotec SE's Cost of Revenue was $203,475 in the quarter ended Dec 31, 2025, up 8.7% from $187,111 a year earlier but down 99.9% from the prior quarter.

Analysis

Evotec SE (EVO) Cost of Revenue (2009 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Cost of Revenue at Evotec SE came in at $761,719, down 99.9% from the prior year.

  • Cost of Revenue shows a five-year compound annual growth rate of -71.8% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Cost of Revenue was $738.26 million in the year ended Dec 31, 2024 (+12.6%), $655.93 million in the year ended Dec 31, 2023 (+7.8%), $608.54 million in the year ended Dec 31, 2022 (+10.2%) and $552.04 million in the year ended Dec 31, 2021 (+28.9%).
  • Quarterly Cost of Revenue has moved between $187,111 (the quarter ended Dec 31, 2024) and $191.67 million (the quarter ended Sep 30, 2025) over five years.
  • Compared with a year earlier, Cost of Revenue has increased for three straight quarters, with an average decline of 11.3% over the last seven quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was the quarter ended Sep 30, 2021 (growth of 26.1%); the worst was the quarter ended Dec 31, 2024 (a decline of 99.9%).
  • Per Business Quant data, EVO's Cost of Revenue in the three quarters before the quarter ended Dec 31, 2025 was $191.67 million (quarter ended Sep 30, 2025), $184.1 million (quarter ended Jun 30, 2025) and $181.72 million (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Iqvia Holdings 42.51 Bn 34.35 Bn 1.44 Bn 2.93 Bn
2 Medpace Holdings 16.73 Bn 14.79 Bn 201.64 Mn 505.69 Mn
3 Charles River Laboratories International 13.84 Bn 13.08 Bn 363.37 Mn 640.70 Mn
4 Icon 12.41 Bn 9.52 Bn 479.29 Mn 1.58 Bn
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn 539.00 Mn
6 Ginkgo Bioworks Holdings 786.20 Mn 24.11 Mn 18.44 Mn 1.72 Mn
7 Evotec SE 568.89 Mn -1.00 Bn - -
8 Champions Oncology 68.76 Mn 44.41 Mn 7.70 Mn 7.53 Mn
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn 1.17 Mn
10 Natural Alternatives International 8.92 Mn -19.16 Mn 1.73 Mn 32.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 203,474.81
Sep 30, 2025 191.67 Mn
Jun 30, 2025 184.10 Mn
Mar 31, 2025 181.72 Mn
Dec 31, 2024 187,111.05
Sep 30, 2024 182.97 Mn
Jun 30, 2024 179.17 Mn
Mar 31, 2024 188.99 Mn
Dec 31, 2023 172.49 Mn
Sep 30, 2023 172.49 Mn
Jun 30, 2023 174.58 Mn
Dec 31, 2022 161.44 Mn
Sep 30, 2022 146.67 Mn
Jun 30, 2022 150.78 Mn
Mar 31, 2022 148.57 Mn
Dec 31, 2021 154.43 Mn
Sep 30, 2021 137.38 Mn
Jun 30, 2021 135.59 Mn
Mar 31, 2021 123.53 Mn
Dec 31, 2020 123.95 Mn
API Access

Evotec SE Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EVO&period=max&api_key=YOUR_API_KEY